ESSA Pharma Inc. is a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer. With a focus on targeting the androgen receptor pathway, ESSA seeks to provide more effective and precise treatments for patients. Through ongoing clinical trials, the company is working towards bringing its innovative therapies to market.
